SRS Capital Advisors »

Acelyrin shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $912 185 4.94
2024-06-30 $815 185 4.41

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Mid Cap Etf (VO)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Schwab Strategic Tr Us Tips Etf (SCHP)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Core Fixed Incom (DFCF)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Apple (AAPL)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Acelyrin

T. Rowe Price Investment Management
AyurMaya Capital Management Company
BlackRock
Millennium Management
Citadel Advisors
Vanguard Group
OrbiMed Advisors
venBio Partners
Tybourne Capital Management
Blue Owl Capital Holdings
General Atlantic
Samsara BioCapital
Morgan Stanley
Opaleye Management
Palo Alto Investors

View all funds holding Acelyrin